Education
About Us
Working with TipRanks
Follow Us
Mark Henry Nawacki Insider Profile
4 Followers
Mark Henry Nawacki, Director at Kane Biotech, holds 15.00K shares in Satellos Bioscience (Ticker: MSLE), holds 665.00K shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Mark Henry Nawacki Bought ― shares of Satellos Bioscience on Mar 14, 2026 for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-16.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Henry Nawacki holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Henry Nawacki
Mark Henry Nawacki's Trading History
Kane Biotech
May 09, 2016
Director
Informative Buy
5.00K
C$23.27K
Satellos Bioscience
Mar 14, 2026
Director
Informative Buy
―
$110.55K
List of latest transactions for each holding click on a transaction to see Mark Henry Nawacki's performance on stock
You May Also Like
Mark Henry Nawacki insider profile FAQ
What is the percentage of profitable transactions made by Mark Henry Nawacki?
The percentage of profitable transactions made by Mark Henry Nawacki is 0%.
What is the average return per transaction made by Mark Henry Nawacki?
The average return per transaction made by Mark Henry Nawacki is -16.20%.
What stocks does Mark Henry Nawacki hold?
Mark Henry Nawacki holds: TSE:KNE, MSLE stocks.
What was Mark Henry Nawacki’s latest transaction?
Mark Henry Nawacki latest transaction was an Informative Buy of ―.
What was Mark Henry Nawacki's most profitable transaction?
Mark Henry Nawacki’s most profitable transaction was an Informative Buy of MSLE stock on March 14, 2026. The return on the trade was 0.00%.
What is Mark Henry Nawacki's role in Kane Biotech?
Mark Henry Nawacki's role in Kane Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.